GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $4.61 $5.48 Friday, 19th Apr 2024 QURE stock ended at $4.67. This is 0.85% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 3.04% from a day low at $4.61 to a day high of $4.75.
90 days $4.61 $6.85
52 weeks $4.61 $22.48

Historical uniQure N.V. prices

Date Open High Low Close Volume
2021-10-22 $28.27 $28.46 $27.74 $28.46 450 130
2021-10-21 $28.59 $28.69 $28.03 $28.24 328 421
2021-10-20 $28.53 $28.87 $28.20 $28.47 282 339
2021-10-19 $28.37 $28.92 $27.85 $28.53 434 790
2021-10-18 $29.72 $29.87 $28.24 $28.27 407 885
2021-10-15 $30.65 $30.65 $29.89 $30.06 259 888
2021-10-14 $30.64 $31.09 $30.36 $30.64 372 191
2021-10-13 $30.60 $31.01 $30.17 $30.31 247 736
2021-10-12 $30.44 $30.96 $30.21 $30.60 213 803
2021-10-11 $30.44 $31.19 $30.22 $30.39 294 056
2021-10-08 $31.22 $31.49 $30.27 $30.45 279 294
2021-10-07 $31.52 $31.88 $30.80 $31.21 331 768
2021-10-06 $31.04 $31.92 $30.53 $31.33 360 674
2021-10-05 $31.05 $31.51 $30.77 $31.33 306 771
2021-10-04 $31.95 $32.76 $30.68 $31.10 282 238
2021-10-01 $31.96 $32.23 $31.43 $32.03 537 981
2021-09-30 $31.52 $32.43 $31.52 $32.01 325 940
2021-09-29 $32.62 $33.07 $31.17 $31.51 582 424
2021-09-28 $33.16 $33.71 $32.19 $32.32 450 778
2021-09-27 $33.60 $34.40 $33.22 $33.30 433 590
2021-09-24 $35.78 $35.83 $33.64 $33.77 538 863
2021-09-23 $38.06 $38.28 $35.69 $35.92 621 474
2021-09-22 $38.29 $38.29 $37.40 $37.87 511 623
2021-09-21 $36.76 $38.80 $36.44 $38.22 738 502
2021-09-20 $35.74 $37.23 $34.82 $36.62 940 967
Click to get the best stock tips daily for free!

About uniQure N.V.

uniQure N.V. uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phas... QURE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT